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Abstract
Background: Protein crystallisation screening involves the parallel testing of large numbers of candidate conditions with the
aim of identifying conditions suitable as a starting point for the production of diffraction quality crystals. Generally,
condition screening is performed in 96-well plates. While previous studies have examined the effects of protein construct,
protein purity, or crystallisation condition ingredients on protein crystallisation, few have examined the effect of the
crystallisation plate.
Methodology/Principal Findings: We performed a statistically rigorous examination of protein crystallisation, and
evaluated interactions between crystallisation success and plate row/column, different plates of same make, different plate
makes and different proteins. From our analysis of protein crystallisation, we found a significant interaction between plate
make and the specific protein being crystallised.
Conclusions/Significance: Protein crystal structure determination is the principal method for determining protein structure
but is limited by the need to produce crystals of the protein under study. Many important proteins are difficult to crystallise,
so that identification of factors that assist crystallisation could open up the structure determination of these more
challenging targets. Our findings suggest that protein crystallisation success may be improved by matching a protein with
its optimal plate make.
Citation: King GJ, Chen K-E, Robin G, Forwood JK, Heras B, et al. (2009) Interaction between Plate Make and Protein in Protein Crystallisation Screening. PLoS
ONE 4(11): e7851. doi:10.1371/journal.pone.0007851
Editor: Joel L. Sussman, Weizmann Institute of Science, Israel
Received July 31, 2009; Accepted October 17, 2009; Published November 16, 2009
Copyright:  2009 King et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by an Australian Research Council (ARC) grant to JLM and BK. BK is an ARC Federation Fellow and a National Health and
Medical Research Council (NHMRC) Honorary Research Fellow. JLM is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: j.martin@imb.uq.edu.au (JLM); S.Blomberg1@uq.edu.au (SPB)
¤a Current address: Centre de Biochimie Structurale, Montpellier, France
¤b Current address: School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, Australia
. These authors contributed equally to this work.
Introduction
Protein crystallography is the major structural biology technique,
accounting for more than 80% of solved protein structures, and
commercially available 96-well plates are essential components of
modern high-throughput protein crystallisation condition screening
[1]. Vapour diffusion is the most frequently used technique for
protein crystallisation[2,3]andisexploitedintwocommonformats,
hanging drop and sitting drop. Both formats involve setting two
solutions, the crystallisation condition or reservoir solution and the
protein drop, within a sealed plate well. The protein drop contains
the protein mixed with the crystallisation condition. The hanging
and sitting drop vapour diffusion formats utilise 96-well plates in
different ways. For the hanging drop method, the protein drop is
suspended above the well solution from a seal and makes no contact
with the crystallisation plate. For the sitting drop method, the
protein drop sits directly on a surface of the crystallisation plate
above the crystallisation condition.
Protein crystallisation is a complex phenomenon involving the
following three processes (1) the slow concentration of components
within the protein drop during equilibration so that the protein
becomes supersaturated, (2) crystal nucleation, and (3) crystal
growth. For crystallisation condition screening, the first two of
these three processes are the most important as the aim is to
identify conditions that can be optimised for crystal growth rather
than to produce diffraction quality crystals.
Many studies have examined the effect of the crystallisation
condition ingredients or the plate geometry on the rate of
equilibration of the protein drop with the crystallisation condition
and both can markedly affect the quality of the crystals [4,5].
Recently, a new model for the equilibration processes was reported
for the hanging drop crystallisation format [6]. This model extends
previously proposed models designed to describe the rate of
equilibration of hanging drop crystallisation experiments, and the
authors consider the effect of well geometry, drop to reservoir
distance, drop volume and precipitant type on the rate of
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7851equilibration.The nucleation process hasalsobeenstudied indetail.
Attempts to control nucleation have been made including seeding
with protein micro-crystals [7], or introducing heterologous
nucleating agents, such as mineral surfaces [8], porous material
with pore sizes on the order of magnitude of protein molecules [9],
and diverse agents such as dried seaweed, horsehair, cellulose and
hydroxyapatite [10,11]. Other workers have shown that nucleation
is affected by the nature of the surface on which the protein drop is
set [12]. In general, these studies indicate that for some proteins,
particular types of surfaces can promote nucleation and crystalli-
sation, though no universal nucleation promoter has yet been
identified. Furthermore, no systematic study has been reported of
the effect on protein crystallisation of different commercial plate
makes.Wethereforesetouttoinvestigate theeffectofplate make on
protein crystallisation success.
Results
We first performed a pilot study to investigate 10 commercially
available plate makes designed for sitting-drop vapour diffusion
protein crystallisation, and a commercially available hanging-drop
plate format used routinely in our laboratories (Table 1). We used
six test proteins, varying in mass from 15 to 60 kDa, that crystallise
under different conditions (eg salt or PEG precipitants, pH range
4.0–8.5). We assessed the crystallisation success of the plates as the
number of drops that gave rise to crystals for each of the 6
proteins. The 11 plates tested appeared to fall into three different
classes. Plates 1, 4, 8, 9 and 11 group together in the class with the
highest crystallisation success (56–58 out of a maximum possible
72 drops with crystals); plates 2, 3 and 7 are in the middle class
(49–51 drops with crystals) and plates 5, 6 and 10 are in the lowest
scoring class (41–44 drops with crystals) (Table 1). The water
permeability of each plate was also investigated over the 37-day
experimental time-frame, to determine if the observed crystallisa-
tion success may be related to dehydration. However, only small
differences in dehydration were measured (Table 1) and these did
not correlate with the observed crystallisation success of the plates.
These initial results did suggest that different plate make might
give rise to different protein crystallisation success but the
conclusions are limited because just one of each plate make was
included in the study.
We therefore extended our study to allow a more statistically
rigorous analysis. We chose three proteins and three plate makes
for further study: two of the plate makes were sitting drop plates
representative of the highest and lowest scoring classes from the
pilot study (Plates 1 and 5, respectively) and the third plate make
was the hanging drop plate (Plate 11) that we use routinely and
which was also classified in the highest scoring class in the pilot
study. We designed an experiment in which nine copies of each of
the three plate makes were tested in crystallisation experiments.
We first examined the resulting data for evidence of variations
in crystallisation success as a consequence of position on the 96-
well plate, which might for example indicate that edge wells
behave differently to wells in the central region of the plate. We
found there was no effect of column number or row number on
crystallisation fraction (rows: b=–0.010, SE=0.062, z=–0.166,
p=0.868; columns: b=–0.015, SE=0.014, z=–1.040, p=0.299)
(see Materials and Methods for further description of these
parameters). We therefore excluded row and column number from
further analyses.
We then used the data set to test the hypothesis that plate make
has a significant effect on crystallisation success, as our pilot data
had suggested. However, the model that allowed different ‘‘within-
plate make’’ variances for the three plate makes was not a
significantly better fit to the data than the simpler, equal variance
model (LR x
2
5=1.683, p=0.891). We could not, therefore, detect
significant differences in the variability in crystallisation fraction
across the three plate makes, for the proteins and conditions used.
Estimates of the standard deviations in crystallisation fraction for
each plate make were, Plate 11: 0.205, Plate 1: 0.347, Plate 5:
0.346. The equal variance model produced a standard deviation of
0.347, 95% HPD interval: (0.339, 0.582). Overall, none of the
Table 1. Crystallisation plates used in this study.
Plate 1 2 3 4 5 6 7 8 9 10 11
a
Material
b Polystyrene Polystyrene Polystyrene Polypropylene COC COC COC PZero Polystyrene Patented
polymer
Polystyrene (plate)
polycarbonate(tape)
Sitting-drop well
Volume (mL)
2 3.9 4.3 3 10 7 4 2 10 5 —
Distance
c (mm) 7.6 3.5 10.5 7 9.1 9.1 8.8 8.9 8.8 8.4 11
Number of drops
with crystals (max
72)
57 49 51 58 41 42 50 56 57 44 58
PEG conc
g %( w / v ) 11.7361.12
#10.9160.53
# 10.5160.06
# 10.2960.06
# 10.0060.06 10.0060.06 10.0060.06 10.7360.24
# 10.5160.06
# 10.0060.06 10.9060.06
#
Water absorption
h ,0.4% ,0.4% ,0.4% 0.03% 0.01% 0.01% 0.01% — ,0.4% — Plate ,0.4% Tape
0.1%
aThis plate was set up for hanging-drop crystallisation, using an adhesive hanging-drop tape rather than a drop well for the protein drops; information on both the plate
and the tape is given.
bPlate material is taken from manufacturer’s information. COC; cyclic olefin copolymer, PZero; Zero polarization polymer.
cDistance from the bottom of the reservoir to the bottom of the sitting-drop well or to the hanging-drop tape, as per manufacturer’s information.
dNtot is the total number of drops with crystals at 37 days, with a theoretical maximum value of Ntot is 72.
gPEG 4000 concentration (% w/v) after 37 days is averaged for 12 replicates (see methods). Values are given for mean (695% confidence intervals, or where no variation
was observed in the 12 replicates, error calculated from the error of the instrument).
#The PEG 4000 concentration after 37 days is significantly different from the starting concentration of 10% (w/v).
hValues for water absorption (after immersion at 23uC for 24 hours) of the plate material are taken from the Goodfellow index of materials (www.goodfellow.com;
Goodfellow Corporation, Oakdale, PA, USA) (and for COC from www.polyplastics.com/en/product/lines/topas/TOPAS.pdf Polyplastics Co., Ltd., Tokyo, Japan). We were
unable to find values for plate material of plates 8 and 10 but our PEG 4000 concentration results suggest that the former is water permeable and the latter has very
low water permeability.
doi:10.1371/journal.pone.0007851.t001
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plates are manufactured very consistently.
Finally, we examined the data for an interaction between plate
make and protein on crystallisation success rate. We found that
there was a statistically significant interaction between plate make
and protein (p,10
26), indicating that plate makes differ in their
ability to grow crystals with different proteins. The analysis
presented in Figure 1 shows that catalase has consistently high
crystallisation fractions across all three plate makes, while for
DsbG plate 11 is statistically inferior to plate 1, but not to plate 5.
The third protein, glucose isomerase, showed the lowest
crystallisation fractions for all plates, with plate 1 being particularly
unsuitable for crystallisation of this protein, under the conditions
used in this experiment.
Discussion
Our findings indicate that crystallisation success may be
improved by matching a protein with its optimal plate make. In
protein crystallisation condition screening using vapour diffusion,
the type of plate used could potentially contribute to three effects
on crystallisation success: an effect on the intrinsic rate of
equilibration of the sealed experiment, an effect on the
equilibration end-point due to changes in the crystallisation
conditions through dehydration, or an effect on the nucleation
of protein crystals. Plate geometry is known to have an effect on
the rate of equilibration of the protein drop [13]. Plate-associated
dehydration could well contribute to increased crystallisation
success, though our pilot study suggested that any dehydration
effect was small and slow and did not correlate with crystallisation
success. The third possible plate effect is a contact effect, where the
surface of the plate may provide, for some proteins, a more or less
effective template for crystal nucleation. There are many reported
examples of heterogeneous nucleating agents on protein crystal-
lisation [13,14] and a specific surface interaction that leads to
either a promotion or an inhibition of crystallisation for some
proteins is perhaps the most likely explanation for the observed
interaction between plate make and protein.
In conclusion, the major finding of this work is that quality
control of protein crystallisation requires optimisation of condi-
tions, including the plate make, and this has never been addressed
before. The correct way to optimise conditions is the use of
properly designed experiments and appropriate statistical analyses
[15,16], though such studies are rare in the literature. While the
present knowledge does not allow one to predict the best match of
a protein to a plate make, we speculate that these issues may be
important for industrial production of protein crystals in large
quantities, and for the study of proteins that are difficult or slow to
crystallise.
Materials and Methods
Pilot Study of Plate Effect on Protein Crystallisation
Crystallisation plates. Ten commercially available 96-well
sitting-drop crystallisation plates (Table 1) were selected on the
basis of diversity of material and sitting-drop well geometry. In the
hanging-drop setup, the drops were prepared on a hanging-drop
seal (TTP4150-5100 sourced from Millennium Science, Victoria,
Australia) that was compatible with the MosquitoH nanolitre
crystallisation robot (TTP LabTech, Melbourn, UK).
Proteins. Six proteins were used: hen egg-white lysozyme
(Roche Diagnostics Corporation, Indianapolis, USA), bovine liver
catalase and Thaumatococcus daniellii thaumatin (Sigma-Aldrich,
Missouri, USA), Streptomyces rubiginosus glucose isomerase
(Hampton Research, California, USA), Eschericheria coli DsbG
[17] and mouse latexin [18]. The crystallisation conditions for
each have been reported previously, though it is not known
whether these are optimised conditions. As necessary, the proteins
were dissolved or dialysed and concentrated for crystallisation
using 10 kDa cut-off centrifugal concentrators (Millipore,
Massachusetts, USA) in the buffers listed in Table 2. Protein
concentration was measured using the Bradford assay (Bio-
Rad
TM, California, USA).
Crystallisation. Three crystallisation conditions were used for
each protein: the precipitant at the published crystallisation
concentration, the precipitant at a concentration 20% lower than
the published condition and the precipitant at a concentration 20%
higher than the reported precipitant concentration (buffer and other
additives conditions remained the same in these three test conditions).
Four replicates were used for each of these three conditions. All the
crystallisation experiments were set up on the same day, in parallel
using the same protein batches (incubated on ice) for each plate.
Protein buffers and crystallisation conditions for each protein are given
in Table 2. Plates were removed from their plastic sleeves just prior to
setting up the experiments to minimise contamination. The
crystallisation condition (85 ml) was placed in the reservoirs of the
crystallisation plates using a BiomekH 2000 Laboratory Automation
workstation (Beckman Coulter, California, USA). The protein drops
constituted 200 nL of protein and 200 nL of crystallisation solution
a n dw e r ep r e p a r e du s i n gaM o s q u i t o H robot (TTP LabTech,
Melbourn, UK) at room temperature. All sitting-drop plates were
sealed using tape (Qiagen, California, USA) and all plates were
incubated in the same incubator (Thermoline, Queensland, Australia)
set to 20uC. In total, 792 crystallisation drops were prepared in one
day. Each of the 11 plates used in this pilot study held 4 replicates of 3
crystallisation conditions for 6 proteins. Images of the crystallisation
experiments were captured using a Crystal Monitor
TM workstation
(Emerald Biosystems, Washington, USA) at the standard settings of
1.0 brightness, 1.0 gamma adjustment and auto exposure for the
highest image resolution (10 s per image). The brightness was adjusted
to 1.25 or 1.5 for plates with dark shadowing around the crystallisation
drop to improve the image quality.
Figure 1. Mean crystallisation fraction for the three proteins on
three different plate makes. A is plate 11, B is plate 1 and C is plate
5. Error bars are 95% confidence intervals. Data were collected from
twenty seven 96-well plates (nine plates of each make) and a total of
864 wells for each protein over the three plate makes.
doi:10.1371/journal.pone.0007851.g001
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crystallisation drops were taken on days 1, 2, 3, 6, 9, 16, 23, 30
and 37. For each of these days and for each plate, the number of
protein drops with crystals was recorded. Crystallisation success,
Ntot, for each plate was defined as the total number of protein
drops with crystals on day 37. Four replicate wells of the three
conditions were set up for each of the six proteins in each of the 11
plates; therefore the theoretical maximum and minimum Ntot
values for each plate were 72 and 0, respectively.
Crystallisation condition dehydration. The refractive
index of PEG solutions was measured using a Bausch and Lomb
Abbe 60 refractometer (Bellingham & Stanley, London, UK) and used
to calculate PEG concentration as described previously [4]. Twelve
85 mL replicates of a 10% w/v PEG 4000 solution were pipetted into
the same 10 types of sitting drop plates and one hanging drop
crystallisation plate used above, and sealed and incubated as described
above. The refractive index of each reservoir solution was measured
before and after a 37 day incubation period and the final PEG 4000
concentration determined using a plot of refractive index versus PEG
4000 concentration (7% to 20% (w/v)) calculated using Prism version
4 (GraphPad Software, California, USA). The mean and 95%
confidence intervals of the PEG 4000 reservoir concentrations were
calculated using Excel (Microsoft, Washington, USA).
Comprehensive Study of Plate Effect on Protein Crystallisation
The experiments for this follow-up statistically rigorous study
were designed to increase the power of the data by increasing
sample size and by decreasing the number of variables by using
constant conditions wherever possible. We therefore chose not to
use different batches of protein, or different batches of crystalli-
sation solutions, but instead produced sufficient quantities of each
protein and of the crystallisation solutions to perform all 27 plate
experiments on the same day under the same conditions. This
approach controls the variability that would result from batch to
batch variation of the protein or the crystallisation condition. We
chose proteins that are known to crystallise, and we chose
conditions under which these proteins are known to crystallise.
Crystallisation plates. Two sitting drop plate makes were
chosen based on their performance in the preliminary analysis, one
from the low success group, Plate 5, and one from the high success
group, Plate 1. We also included the hanging drop plate, Plate 11,
because it is routinely used in our labs and scored well in the pilot study.
Proteins. Three proteins were used for the comprehensive
study: bovine liver catalase, Streptomyces rubiginosus glucose
isomerase and Eschericheria coli DsbG and prepared as described
for the initial study (Table 2).
Crystallisation. Both hanging- and sitting-drop experiments
were set up using the MosquitoH nanolitre crystallisation robot
(TTP LabTech, Melbourn, UK). Each drop was built by adding
200 nL of the crystallisation condition to 200 nL of the protein
solution. The crystallisation conditions are listed in Table 2.
A total of 27 plates, nine of each of the three plate makes, were set
withcrystallisation drops.Eachproteinwasrepresentedon every one of
the 27 plates by either 24 or 36 drops, and a total of 864 wells were set
for each protein (total of 2,592 wells altogether). Plates were incubated
at 20uC in a Formulatrix RockImager (Formulatrix, Massachusetts
USA). The crystallisation drops were imaged with a Formulatrix
RockImager at: 0, 1, 2, 3, 5, 8, 13 and 21 days. The presence of crystals
in a well at 21 days was taken as a crystallisation success.
Statistical analysis. We used binomial generalised linear
mixed-effects models (GLMMs) with a logit link to analyse the
crystallisation fractions (fraction of wells containing crystals). All
analyses were performed in R 2.7.1, using the lme4 package
[19,20]. We treated plate make (3 levels, one for each plate make)
and protein (3 levels: catalase, DsbG, and glucose isomerase) as
fixed factors, and row number and column number for each well
as covariates. Within-make, plate-to-plate variation was accounted
for by including plate ID as a random factor (Equation 2).
log
p
1{p

~b0zb1PlateMakezb2Proteinzb3PlateMake : Protein
zb4RowNumberzb5ColumnNumber
zb1PlateIDze,
eN 0,s2 
b1N 0,t2 
ð2Þ
The experimental design allowed us to test whether crystalli-
sation fraction varied with plate make or protein, with row or
Table 2. Proteins and crystallisation conditions used in this study.
Protein Lysozyme
1 Catalase
1 Latexin Glucose isomerase
2 DsbG
3 Thaumatin
1
Molecular Weight (kDa) 14.7 (Monomer) 57.6 (Monomer) 25.7 (Monomer) 43.2 (Monomer) 51.4 (Dimer) 22 (Monomer)
Protein concentration
used/reported (mg/ml)
54/75 10/10 11/7 24/20 13/13 40/50
Protein buffer 100 mM Na acetate,
pH 4.8, 0.02% (w/v)
Na azide
25 mM Tris-HCl,
pH 7.0
25 mM Tris-HCl,
pH 7.0
6 mM Tris-HCl, pH 7.0,
1 mM MgSO4
25 mM HEPES, pH 7.0,
50 mM NaCl
MilliQ Water
Crystallisation condition 25 mM Na acetate,
pH 4.8, 0.02% (w/v)
Na azide, 1.1 M NaCl
4
100 mM Tris-HCl,
pH 8.5, 8% (w/v)
PEG 8000
5
100 mM cacodylate,
pH 6.5, 1.8 M
(NH4)2SO4
6
100 mM HEPES, pH 7.2,
1.4 M (NH4)2SO4
4
100 mM Na citrate,
pH 4.0, 22% (w/v) PEG
4000, 200 mM (NH4)2SO4
7
0.1 M ADA, pH 6.5,
1 M K/Na tartrate
8
1Lysozyme, catalase and thaumatin were dissolved in their respective protein buffers.
2Glucose isomerase was dialysed for 24 hours at 4uC in its protein buffer.
3DsbG was exchanged into its protein buffer prior to concentration.
4From Rigaku Corporation crystallisation procedures (http://www.rigaku.com).
5Hampton Research crystal screen I condition 36 (http://www.hamptonresearch.com). ADA, N-(2-acetamido)-iminodiacetic acid; HEPES, 4-(2-hydroxyethyl) piperazine-1-
ethanesulfonic acid; Tris, tris(hydroxymethyl)aminomethane.
6See reference [18].
7See reference [17].
8See reference [23].
doi:10.1371/journal.pone.0007851.t002
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among plates. Only wells where the crystallisation drop had been
set successfully were included in the analysis: 64 wells were
removed owing to poor set-up of the drop by the robot. Drops
were scored positive for crystallisation if crystals appeared on or
before day 21. Tests of fixed effects are problematic in mixed-
effects models because the distribution of the fixed effects is
uncertain under the null hypothesis. In particular, denominator
degrees of freedom for F tests are difficult to determine (Bates,
personal communication). To circumvent this problem, we tested
the significance of the protein type–plate make interaction by
sampling from the posterior distribution of the fixed effects using
Markov Chain Monte Carlo (e.g. [21]). We took 10
6 samples from
the joint posterior distribution of the fixed effects, checked the
traces for lack of convergence, and examined histograms of the
marginal posterior distributions. We obtained a p-value for this
interaction under the null hypothesis of a mean of zero, against the
alternative of a general elliptic multivariate distribution. This
allowed us to test whether the effect of plate make on the
crystallisation fraction varied according to protein. We tested
whether the within-make variation differed due to plate make, to
examine whether any plate make had more consistent results than
the others. To test this hypothesis, we fitted a model that allowed
different variances for the plate makes, and compared it to a model
with equal variance for all plate makes, using a likelihood ratio
test. We examined quantile-quantile plots of the residuals and the
random effects to look for departures from normality, and plots of
the residuals versus the fitted values to check for heteroscedasticity
and nonlinearity in the residuals [22].
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